| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |